*In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
In the genetic analysis, each genetically predicted 1 kg/m lower BMI through GLP-1R activation corresponded to approximately 18% lower odds of major depressive disorder and 39% lower odds of bipolar disorder
[PMID: 10703712] PubMed record related to this compound for laboratory literature review
Inflammation and the Final Turn of the Screw : Visceral adipose tissue releases a host of inflammatory molecules called adipokines (e.g., TNF-alpha, IL-6)
The homologous recombination (HR) pathway is also a critical pathway for enhanced DNA repair capacity, especially in cases of cross-linking by platinum-based anti-cancer agents